Profil
Daniel B. Wolfe is President, Chief Executive Officer & Director at Synglyco, Inc. Dr. Wolfe is Managing Director at BC Partners, Inc. starting in 2025.
Dr. Wolfe is Director at Phoenix Molecular Corp.
Dr. Wolfe is Director at Prosep USA, Inc. Dr. Wolfe is Director at Parabellum Acquisition Corp.
since 2021.
Dr. Wolfe is Vice President at Continental Stock Transfer & Trust Co. Dr. Wolfe is President & Chief Operating Officer at Harris & Harris Enterprises, Inc. since 2009.
Dr. Wolfe is President, Chief Financial & Compliance Officer at 180 Degree Capital since 2017.
Former roles include President, Chief Financial Officer & Director at 180 Degree Capital Corp.
from 2017 to 2025.
Dr. Wolfe was Director at Evolved Nanomaterial Sciences, Inc., SiOnyx LLC, Laird Durham, Inc., Laser Light Engines, Inc., Produced Water Absorbents, Inc., and Ultora, Inc. Dr. Wolfe was Director at Enumeral Biomedical Holdings, Inc. from 2014 to 2015.
Dr. Wolfe was Director & Secretary at Enumeral Biomedical Corp.
in 2011.
Dr. Wolfe was President, CFO & Chief Compliance Officer at 180 Degree Capital Corp.
(Investment Management) from 2016 to 2025.
Dr. Wolfe was President at Scientific Venture Assessments, Inc. from 2000 to 2002.
Education includes a doctorate and graduate degree from Harvard University and an undergraduate degree from William Marsh Rice University conferred in 1999.
Postes actifs de Daniel Wolfe
| Sociétés | Poste | Début |
|---|---|---|
| PARABELLUM ACQUISITION CORP. | Directeur/Membre du Conseil | 27/09/2021 |
180 Degree Capital
180 Degree Capital Investment Trusts/Mutual FundsMiscellaneous Operates as closed-end management investment company | Directeur Financier/CFO | 01/07/2016 |
Continental Stock Transfer & Trust Co.
Continental Stock Transfer & Trust Co. Investment Banks/BrokersFinance Specializes in stock transfer services | Corporate Officer/Principal | - |
Prosep USA, Inc.
Prosep USA, Inc. Oilfield Services/EquipmentIndustrial Services Provides integrated oil, gas and water separation solutions | Directeur/Membre du Conseil | - |
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Directeur Général | - |
Harris & Harris Enterprises, Inc. | President | 01/01/2009 |
Phoenix Molecular Corp. | Directeur/Membre du Conseil | - |
BC Partners, Inc.
BC Partners, Inc. Investment ManagersFinance BC Partners focuses on leading buy-outs of larger businesses in the region and selectively outside Europe through its established network of offices in London, Paris, Hamburg, Milan and New York. The firm is an active, long-term manager that concentrates on large, multi-country transactions which typically have significant operations in Europe even when the principal place of business is elsewhere. They target a small number of companies, seeking a seat on the board of directors and partnering with management to implement the business plan and identify opportunities for value creation. BC Partners typically invests in high quality businesses which enjoy strong competitive positions in their industry. They focus on business fundamentals rather than sector specialization, placing particular value on pricing or cost leadership, demonstrated resilience to cycle downturns, profit improvement potential, and a high quality management team. The firm can invest over €2 billion per transaction and can contribute significant financial reserves to grow an acquired business. | Private Equity Investor | 01/09/2025 |
Anciens postes connus de Daniel Wolfe
| Sociétés | Poste | Fin |
|---|---|---|
| 180 DEGREE CAPITAL | Directeur Financier/CFO | 02/09/2025 |
| ░░░ ░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Daniel Wolfe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
180 Degree Capital Corp.
180 Degree Capital Corp. Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
Continental Stock Transfer & Trust Co.
Continental Stock Transfer & Trust Co. Investment Banks/BrokersFinance Specializes in stock transfer services | Finance |
Evolved Nanomaterial Sciences, Inc.
Evolved Nanomaterial Sciences, Inc. Pharmaceuticals: OtherHealth Technology Manufactures chiral drugs | Health Technology |
SiOnyx LLC
SiOnyx LLC SemiconductorsElectronic Technology Develops and manufactures CMOS image sensors | Electronic Technology |
Laird Durham, Inc.
Laird Durham, Inc. Electronic Production EquipmentElectronic Technology Designs & manufactures thermal and power management products | Electronic Technology |
Synglyco, Inc.
Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Develops novel vaccines using synthetic carbohydrates | Health Technology |
Laser Light Engines, Inc.
Laser Light Engines, Inc. Electrical ProductsProducer Manufacturing Develops digital light technologies for movies | Producer Manufacturing |
Harris & Harris Enterprises, Inc. | |
Enumeral Biomedical Holdings, Inc.
Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Develops novel antibody immunotherapies designed to help immune system attack diseased cells | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
180 Degree Capital
180 Degree Capital Investment Trusts/Mutual FundsMiscellaneous Operates as closed-end management investment company | Miscellaneous |
Phoenix Molecular Corp. | |
Scientific Venture Assessments, Inc. | |
Enumeral Biomedical Corp.
Enumeral Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases | Commercial Services |
Produced Water Absorbents, Inc.
Produced Water Absorbents, Inc. Environmental ServicesIndustrial Services Provides waste treatment solutions and services to the oil and gas industry | Industrial Services |
BC Partners, Inc.
BC Partners, Inc. Investment ManagersFinance BC Partners focuses on leading buy-outs of larger businesses in the region and selectively outside Europe through its established network of offices in London, Paris, Hamburg, Milan and New York. The firm is an active, long-term manager that concentrates on large, multi-country transactions which typically have significant operations in Europe even when the principal place of business is elsewhere. They target a small number of companies, seeking a seat on the board of directors and partnering with management to implement the business plan and identify opportunities for value creation. BC Partners typically invests in high quality businesses which enjoy strong competitive positions in their industry. They focus on business fundamentals rather than sector specialization, placing particular value on pricing or cost leadership, demonstrated resilience to cycle downturns, profit improvement potential, and a high quality management team. The firm can invest over €2 billion per transaction and can contribute significant financial reserves to grow an acquired business. | Finance |
Ultora, Inc.
Ultora, Inc. Electronic ComponentsElectronic Technology Develops energy storage devices such as capacitators | Electronic Technology |
Prosep USA, Inc.
Prosep USA, Inc. Oilfield Services/EquipmentIndustrial Services Provides integrated oil, gas and water separation solutions | Industrial Services |
Parabellum Acquisition Corp.
Parabellum Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
180 Degree Capital Corp. (Investment Management)
180 Degree Capital Corp. (Investment Management) Investment ManagersFinance 180-IM aims to generate capital appreciation and current income from investments and investment-related activities. The firm focuses on publicly traded micro-cap companies and invests where their research suggests a company is deeply undervalued and can positively impact the business and valuation through constructive activism. | Finance |
















